beta Lactam Antibiotics
DBCAT005892Pharmacologic class
Bactericidal agents that contain a beta-lactam ring in their chemical structure. They inhibit bacterial cell wall synthesis by binding to PENICILLIN-BINDING PROTEINS, preventing the synthesis of peptidoglycan in bacterial cell walls. A DrugBank category of 10 drugs. 9 of them are approved.
What you can answer from here — as of December 03, 2023
Which targets do beta Lactam Antibiotics share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account